CNR Institutional Research Information System

CATUOGNO, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 883
NA - Nord America 541
EU - Europa 351
SA - Sud America 223
AF - Africa 24
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.026
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 493
SG - Singapore 399
BR - Brasile 181
CN - Cina 171
IT - Italia 161
VN - Vietnam 106
HK - Hong Kong 102
FR - Francia 52
NL - Olanda 47
KR - Corea 29
CA - Canada 26
JP - Giappone 22
AR - Argentina 21
DE - Germania 21
MX - Messico 14
FI - Finlandia 13
AT - Austria 12
GB - Regno Unito 10
BD - Bangladesh 9
IN - India 9
EC - Ecuador 7
ZA - Sudafrica 7
IL - Israele 6
IQ - Iraq 6
IE - Irlanda 5
AL - Albania 4
CO - Colombia 4
EG - Egitto 4
PY - Paraguay 4
ES - Italia 3
ID - Indonesia 3
MA - Marocco 3
PK - Pakistan 3
UA - Ucraina 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
NP - Nepal 2
NZ - Nuova Zelanda 2
RS - Serbia 2
RU - Federazione Russa 2
SI - Slovenia 2
TR - Turchia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
ME - Montenegro 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
ZM - Zambia 1
Totale 2.026
Salva come PNG Salva come JPEG
Città #
Singapore 240
Santa Clara 129
Hong Kong 102
Beijing 45
Lauterbourg 44
San Jose 43
Hefei 42
Ho Chi Minh City 40
Ashburn 38
Milan 35
Los Angeles 34
Marigliano 30
Seoul 28
Hanoi 24
São Paulo 21
Tokyo 19
Naples 16
Montreal 12
Dallas 11
New York 11
Frankfurt am Main 10
Helsinki 10
Vienna 8
Da Nang 6
Buffalo 5
Figino 5
Houston 5
Johannesburg 5
Phoenix 5
Biên Hòa 4
Casandrino 4
Dublin 4
Düsseldorf 4
Orem 4
Princeton 4
Rio de Janeiro 4
Toledo 4
Ascoli Piceno 3
Atlanta 3
Avellino 3
Baltimore 3
Belo Horizonte 3
Bengaluru 3
Betim 3
Brasília 3
Brooklyn 3
Cairo 3
Council Bluffs 3
Genoa 3
Guarulhos 3
Guayaquil 3
London 3
Manaus 3
Medford 3
Miami 3
Minamishinagawa 3
Palermo 3
Plano 3
Quito 3
São Gonçalo 3
São José dos Pinhais 3
The Bronx 3
Thái Bình 3
Toronto 3
Alegrete 2
Almirante Tamandaré 2
Amsterdam 2
Auckland 2
Baghdad 2
Berlin 2
Bogotá 2
Boydton 2
Burnsville 2
Caivano 2
Campinas 2
Campos dos Goytacazes 2
Cape Town 2
Ciudad del Este 2
Colombo 2
Columbiana 2
Cà Mau 2
Dhaka 2
Falkenstein 2
Feira de Santana 2
Fostoria 2
Hagerstown 2
Haiphong 2
Hải Dương 2
Ilhéus 2
Jacksonville 2
Kingston 2
Lappeenranta 2
Mexico City 2
Milwaukee 2
Mustang 2
Nairobi 2
New Delhi 2
Newark 2
Ninh Bình 2
Omaha 2
Totale 1.208
Salva come PNG Salva come JPEG
Nome #
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes 96
New aptamer-based approaches for the targeting of cancer associated fibroblast in NSCLC 85
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation 79
Directing in Vitro Selection towards G-quadruplex-forming Aptamers to Inhibit HMGB1 Pathological Activity 79
Selection of a nuclease‐resistant rna aptamer targeting cd19 72
STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts 71
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy 70
Emerging therapeutic RNAs for the targeting of cancer associated fibroblasts 65
Stick-based methods for aptamer-mediated siRNA targeted delivery 63
Aptamer-based RNA-bio-drugs for the combined therapy of GBM 60
The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses 60
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR beta Aptamer 59
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 57
Selection of RNA aptamers targeting hypoxia in cancer 54
Advances in mRNA non-viral delivery approaches 54
Advances in Oligonucleotide Aptamers for NSCLC Targeting 54
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 54
STAT3 targeting by an aptamer-based conjugate for glioblastoma multiforme therapy 51
Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer 50
Nucleic acid aptamers targeting epigenetic regulators: An innovative therapeutic option 50
Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3 47
Identification of an interfering ligand aptamer for EphB2/3 receptors 46
Nucleic acids delivering nucleic acids 45
Targeting breast cancer exosomes with nucleic aptamers: Innovative tools for early diagnosis and therapy 44
An anti-PDGFR aptamer for selective delivery of small therapeutic peptide to cardiac cells 43
Aptamer chimeras for therapeutic delivery: The challenging perspectives 43
Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates 40
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma 40
Targeting Insulin Receptor with a Novel Internalizing Aptamer. 34
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis 33
A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells 32
Aptamer-miRNA conjugates for cancer cell-targeted delivery 32
cleic acids in human glioma treatment: innovative approaches and recent results 30
Coupling aptamers to short interfering RNAs as therapeutics 30
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR? Aptamer. 30
A Trojan horse for human immunodeficiency virus 29
Aptamer-mediated targeted delivery of therapeutics: An update 29
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models 29
Recent advance in biosensors for microRNAs detection in cancer 28
New insight into clinical development of nucleic acid aptamers. 27
SERS-active metal-dielectric nanostructures integrated in microfluidic devices for label-free quantitative detection of miRNA 27
Electrochemical detection of miRNA-222 by use of a magnetic bead-based bioassay 26
Developing aptamers by cell-based SELEX 25
Aptamer cell-based selection: Overview and advances 24
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells 24
Directing in Vitro Selection towards G‐quadruplex‐forming Aptamers to Inhibit HMGB1 Pathological Activity 23
Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation 19
The chimeric aptamer axl-miR-214sponge inhibits breast cancer and melanoma dissemination 18
Unraveling the NMR structures of G-quadruplex-forming aptamers acting as inhibitors of High Mobility Group Box 1 (HMGB1) pathological activity 4
Totale 2.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.228
article - articoli 6.889
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 339
Totale 14.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202440 0 0 0 0 0 0 0 0 1 0 27 12
2024/2025849 8 1 57 28 125 59 87 84 44 61 157 138
2025/20261.223 43 102 142 196 224 75 164 49 58 87 51 32
2026/202772 72 0 0 0 0 0 0 0 0 0 0 0
Totale 2.184